
SC Medica announced that its FFX Facet FiXation System received FDA 510(k) clearance for cervical use.
Following the recent FDA authorization of FFX for standalone lumbar facet arthrodesis, this new clearance further confirms the system’s role as an emerging standard in posterior stabilization.
With more than 11,000 implantations worldwide to date, FFX stabilizes the posterior column through bilateral facet joint immobilization, simplifying the surgical workflow, reducing operative time and lowering surgical morbidity vs. conventional fixation systems.
“This new cervical indication represents another major step forward for facet-based stabilization,” said Camille Srour, Ph.D., Founder and CEO of SC Medica. “This reflects our long-standing commitment to achieving fusion with the Minimum Necessary Volume of Instrumentation – a concept we call MiNVI.”
Source: SC Medica
SC Medica announced that its FFX Facet FiXation System received FDA 510(k) clearance for cervical use.
Following the recent FDA authorization of FFX for standalone lumbar facet arthrodesis, this new clearance further confirms the system’s role as an emerging standard in posterior stabilization.
With more than 11,000 implantations worldwide...
SC Medica announced that its FFX Facet FiXation System received FDA 510(k) clearance for cervical use.
Following the recent FDA authorization of FFX for standalone lumbar facet arthrodesis, this new clearance further confirms the system’s role as an emerging standard in posterior stabilization.
With more than 11,000 implantations worldwide to date, FFX stabilizes the posterior column through bilateral facet joint immobilization, simplifying the surgical workflow, reducing operative time and lowering surgical morbidity vs. conventional fixation systems.
“This new cervical indication represents another major step forward for facet-based stabilization,” said Camille Srour, Ph.D., Founder and CEO of SC Medica. “This reflects our long-standing commitment to achieving fusion with the Minimum Necessary Volume of Instrumentation – a concept we call MiNVI.”
Source: SC Medica
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





